Alkeon Capital Management
ALNY icon

Alkeon Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Alkeon Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-390,551
Closed -$73.7M – 156
2021
Q3 		$73.7M Sell
390,551
-268,031
-41% -$50.3M 0.12% 106
2021
Q2 		$112M Hold
658,582
– – 0.16% 101
2021
Q1 		$93M Buy
658,582
+76,497
+13% +$11.5M 0.14% 104
2020
Q4 		$75.7M Buy
582,085
+141,109
+32% +$18.8M 0.12% 105
2020
Q3 		$64.2M Sell
440,976
-66,524
-13% -$9.45M 0.12% 98
2020
Q2 		$75.2M Buy
507,500
+62,500
+14% +$8.43M 0.19% 82
2020
Q1 		$48.4M Buy
445,000
+15,000
+3% +$1.73M 0.21% 82
2019
Q4 		$49.5M Sell
430,000
-307,500
-42% -$30.7M 0.18% 85
2019
Q3 		$59.3M Buy
737,500
+185,000
+33% +$14.6M 0.21% 87
2019
Q2 		$40.1M Buy
552,500
+150,000
+37% +$11.5M 0.16% 92
2019
Q1 		$37.6M Buy
402,500
+232,500
+137% +$19.4M 0.19% 94
2018
Q4 		$12.4M Buy
+170,000
New +$13.1M 0.08% 106
2018
Q2 		– Sell
-4,540
Closed -$541K – 124
2018
Q1 		$541K Sell
4,540
-460
-9% -$59.3K ﹤0.01% 118
2017
Q4 		$635K Buy
+5,000
New +$628K ﹤0.01% 87

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Alkeon Capital Management's ALNY Position: Q4 2021 in Review

Alkeon Capital Management sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2021, closing a stake of 390,551 shares — an estimated $73.7M sold.

Alkeon Capital Management first reported a position in ALNY in Q4 2017 and held it in 14 quarters. The position peaked at $112M in Q2 2021. 433 funds tracked by Wall St. Rank hold ALNY as of Q4 2021.

  • Alkeon Capital Management reported no remaining Alnylam Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Alkeon Capital Management sold 390,551 Alnylam Pharmaceuticals shares in Q4 2021, an estimated $73.7M.
  • Alkeon Capital Management first reported a position in Alnylam Pharmaceuticals in Q4 2017 and held it in 14 quarters.
  • Alkeon Capital Management's Alnylam Pharmaceuticals position peaked at $112M in Q2 2021.
  • 433 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2021.

Based on Alkeon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.